Friday, May 13, 2016

BRIEF-Navidea Biopharmaceuticals says received demand for arbitration from CEO Ricardo Gonzalez

* On May 12, received a demand for arbitration from Ricardo

Gonzalez, company's chief executive officer - sec filing

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)